Regulus Therapeutics (RGLS) Stock | Here’s What You Need To Know

Regulus Therapeutics (NASDAQ:RGLS) In after-hours trade on Monday June 27, 2016 shares of Regulus Therapeutics tanked as much as 60% after the company announced that the FDA had placed their Hepatitis C drug on a clinical hold. It is not a good thing that the company’s drug, RG-101 has been placed on a clinical hold. … Read more

Biotech Stock News (IMGN) (RGLS) (GILD) (ACHN) (OPK) (BRLI)

Immunogen (NASDAQ:IMGN) Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy … Read more

Biotech News- 2/9/15 to 2/13/15

Achillion Pharmaceuticals (ACHN) Shares of Achillion gained 7% on 2/9/15 last week when it had announced that it had achieved a 100% SVR12 in a phase 2 trial treating patients with the genotype 1 version of the Hepatitis C virus — HCV. The trial tested for the primary objective of patients being able to achieve a … Read more